日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Sweat components as a promising monitoring tool for systemic diseases

汗液成分作为一种有前景的全身性疾病监测工具

Shi, Changqi; Chen, Ziyi; Zhang, LuLu; Zhang, Xiaomeng; Liang, Xiaoyu; Yan, Lan; Hao, Xiaopeng; Dong, Guoju; Lu, Cheng; Huang, Luqi

Prediction models and risk scores in different types of heart failure: a review

不同类型心力衰竭的预测模型和风险评分:综述

Wei, Yue; Liu, Siyu; Mu, Yunying; Liang, Xiaoyu; Chen, Ziyi; Liu, Yongcheng; Dong, Guoju

Efficacy of Danlou tablets in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a multicenter prospective cohort study

丹洛片治疗接受经皮冠状动脉介入治疗的急性冠脉综合征患者的疗效:一项多中心前瞻性队列研究

Cai, Yajie; Yang, Qiaoning; Xi, Ruixi; Yang, Furong; Gu, Feng; Zhao, Yang; Guo, Ming; Dong, Guoju; Gao, Zhuye; Fu, Changgeng; Wang, Peili; Du, Jianpeng; Zhang, Dawu; Duan, Wenhui; Li, Lizhi; Shi, Dazhuo; Bai, Ruina

Development and Challenges of Pre-Heart Failure with Preserved Ejection Fraction

射血分数保留型心力衰竭前期的发展和挑战

Dong, Guoju

Clinical Implications of Plasma Galectin-3 in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis

血浆半乳糖凝集素-3在射血分数保留型心力衰竭中的临床意义:一项荟萃分析

Shi, Yujiao; Dong, Guoju; Liu, Jiangang; Shuang, Xiong; Liu, Chunqiu; Yang, Chenguang; Qing, Wang; Qiao, Wenbo

Diagnostic and prognostic value of serum soluble suppression of tumorigenicity-2 in heart failure with preserved ejection fraction: A systematic review and meta-analysis

血清可溶性肿瘤抑制因子-2在射血分数保留型心力衰竭中的诊断和预后价值:系统评价和荟萃分析

Shi, Yujiao; Liu, Jiangang; Liu, Chunqiu; Shuang, Xiong; Yang, Chenguang; Qiao, Wenbo; Dong, Guoju

Efficacy and safety of Chinese herbal medicine versus Lopinavir-Ritonavir in adult patients with coronavirus disease 2019: A non-randomized controlled trial

中药与洛匹那韦/利托那韦治疗2019冠状病毒病成人患者的疗效和安全性比较:一项非随机对照试验

Shi, Nannan; Guo, Lanping; Liu, Bin; Bian, Yongjun; Chen, Renbo; Chen, Suping; Chen, Yang; Chen, Yingying; Cong, Xiaodong; Dong, Guoju; Guo, Jing; Hu, Lijie; Jiang, Jianxin; Leng, Luxing; Li, Bin; Li, Dongxu; Li, Hao; Li, Jing; Li, Li; Liu, Jia; Lu, Cheng; Lv, Wenliang; Miao, Qing; Qi, Wensheng; Shi, Zhan; Shi, Jiaheng; Shi, Huaxin; Tian, Yaxin; Wang, Bing; Wang, Gang; Wang, Jian; Wang, Wei; Xian, Yongyue; Xie, Xiaolei; Xiong, Yibai; Xu, Chunyan; Xu, Ming; Yan, Bei; Yang, Jinliang; Zhang, Li; Zhou, Zhenqi; Zhu, Haoning; Huang, Luqi

Combination of Hua Shi Bai Du granule (Q-14) and standard care in the treatment of patients with coronavirus disease 2019 (COVID-19): A single-center, open-label, randomized controlled trial

华石白毒颗粒(辅酶Q14)联合标准治疗治疗2019冠状病毒病(COVID-19)患者的疗效:一项单中心、开放标签、随机对照试验

Liu, Jia; Yang, Wei; Liu, Yue; Lu, Cheng; Ruan, Lianguo; Zhao, Chen; Huo, Ruili; Shen, Xin; Miao, Qing; Lv, Wenliang; Li, Hao; Shi, Huaxin; Hu, Lijie; Yang, Zhixu; Zhang, Li; Wang, Bing; Dong, Guoju; Xian, Yongyue; Li, Bin; Zhou, Zhenqi; Xu, Chunyan; Chen, Yingying; Bian, Yongjun; Guo, Jing; Yang, Jinliang; Wang, Jian; Qi, Wensheng; Chen, Suping; Chen, Yang; Yan, Bei; Wang, Wei; Li, Jing; Xie, Xiaolei; Xu, Ming; Jiang, Jianxin; Wang, Gang; Cong, Xiaodong; Zhu, Haoning; Shi, Jiaheng; Leng, Luxing; Li, Dongxu; Guo, Lanping; Huang, Luqi

Traditional formula, modern application: chinese medicine formula sini tang improves early ventricular remodeling and cardiac function after myocardial infarction in rats.

传统配方,现代应用:中药方剂四逆汤可改善大鼠心肌梗死后的早期心室重构和心脏功能

Liu Jiangang, Peter Karoline, Shi Dazhuo, Zhang Lei, Dong Guoju, Zhang Dawu, Breiteneder Heimo, Jakowitsch Johannes, Ma Yan